Investor Relations

Amgen Investor Relations (AMGN) Guide

By 
Brian Thorp
Brian Thorp is the founder and CEO of Wealthtender and Editor-in-Chief. Prior to founding Wealthtender, Brian spent nearly 22 years in multiple leadership roles at Invesco. With over 25 years in the financial services industry, Brian is applying his experience and passion at Wealthtender to help more people enjoy life with less money stress.

Learn about our Editorial Policy.

Wealthtender is a trusted, independent financial directory and educational resource governed by our strict Editorial Policy, Integrity Standards, and Terms of Use. While we receive compensation from featured professionals (a natural conflict of interest), we always operate with integrity and transparency to earn your trust. Wealthtender is not a client of these providers. ➡️ Find a Local Advisor | 🎯 Find a Specialist Advisor

Amgen Investor Relations: Important Information to Know

Are you currently an investor in Amgen (ticker: AMGN) through a brokerage account? Or do you own AMGN stock as an employee through your Amgen benefits plan?

No matter how you own stock in Amgen or if you’re just thinking about investing, the resources provided on this page will help you become a more informed investor.

You’ll find important information to help you quickly connect to the details you’re looking for about Amgen Investor Relations, including direct links to their most recent press releases, earnings reports, SEC filings, and other useful tools for investors.

Important InformationLinks and Details
Amgen Investor Relations Departmentinvestors.amgen.com
Amgen Press Releasesinvestors.amgen.com/news-and-events/press-releases
Amgen SEC Filingsinvestors.amgen.com/financials/sec-filings
Amgen EarningsView Amgen Earnings Reports (including: Presentations, Conference Calls)
Amgen Events Calendarinvestors.amgen.com/news-and-events/events-calendar
Amgen Investor FAQsView frequently asked questions with answers from Amgen’s investor relations department
Amgen Stock Quoteinvestors.amgen.com/stock/stock-information
How is interest in Amgen Stock Trending?View Google Trends for Amgen Stock

Brian Thorp

About the author

Brian Thorp

Founder & CEO and Editor-in-Chief, Wealthtender

Brian Thorp is the founder and CEO of Wealthtender and its Editor-in-Chief. With more than 25 years in the financial services industry, he is applying his experience and passion at Wealthtender to help more people enjoy life with less money stress.

Brian and his wife live in Austin, Texas.

Wealthtender is a trusted, independent financial directory and educational resource governed by our strict Editorial Policy, Integrity Standards, and Terms of Use. While we receive compensation from featured professionals (a natural conflict of interest), we always operate with integrity and transparency to earn your trust. Wealthtender is not a client of these providers. ➡️ Find a Local Advisor | 🎯 Find a Specialist Advisor